Linda Vo, PhD

Principal Investigator, Innovative Genomics Institute

Linda Vo obtained her Ph.D. from Harvard Medical School in stem cell biology and hematology/oncology. As a National Science Foundation fellow in Dr. George Daley’s lab, her research focused on defining key pathways that enable the efficient generation of clinically useful blood cells from renewable sources like induced pluripotent stem cells. She developed strategies to generate hematopoietic stem and progenitor cells from pluripotent stem cells for disease modeling and cell therapy. Supported by the Damon Runyon Cancer Research Foundation, she completed her postdoctoral fellowship with Dr. Jeffrey Bluestone at UCSF, where she leveraged her expertise in hematopoietic differentiation to engineer antigen-specific T cells from pluripotent stem cells for cancer immunotherapy and autoimmune disease treatment. She joined the IGI Center for Translational Genomics in 2021 to spearhead efforts to advance HSC and T cell therapies using CRISPR-based genome editing technologies.